On Wednesday, Humana said it's exiting all Affordable Care Act marketplaces in 2018, Molina Healthcare announced it might do the same—and Aetna's CEO declared that the exchanges are in a "death spiral." The Daily Briefing’s Josh Zeitlin spoke to top experts to find out what's really going on.
An advisory panel to the National Academy of Sciences and the National Academy of Medicine on Tuesday issued a report supporting clinical trials into editing genes in sperm, eggs, and early-stage embryos—but only under certain narrow circumstances.
IRS earlier this month quietly reversed a plan established under the Obama administration to reject 2016 tax returns that do not indicate whether the filers complied with the Affordable Care Act's individual mandate.
The Daily Briefing spoke with Winn Halverhout, Steve Levine, and Fred Miles of Husch Blackwell LLP about the main challenges facing providers related to medical marijuana, how the new administration might change the legal landscape, and more.